Author:
Cardwell Terence J.,Edwards Alison J.,Hartshorn Richard M.,Holmes Rodney J.,McFadyen W. David
Abstract
A number of mixed-ligand cobalt(III) complexes containing either the ligand
2-aminomethylbenzimidazole (ambi) or its N-methyl
derivative, namely 2-(N-methylaminomethyl)benzimidazole (mambi), have been
prepared in relatively low yield; in particular, the complexes
[Co(ambi)(acac)2] Cl,
[Co(ambi)(Clacac)2] Cl,
K[Co(ambi)(ox)2],[Co(ambi)2(acac)]
(ClO4)2,
[Co(mambi)(acac)2] Cl and
[Co(mambi)(Clacac)2 ]Cl (acac =
acetylacetonate, Clacac = 3-chloroacetylacetonate, ox =
oxalate). The reduction potentials of these complexes have been measured in
order to assess whether molecules of this type could be potential
redox-activated hypoxic cell selective anticancer agents. The complex
[Co(ambi)(acac)2]
Cl.4·1H2O was characterized by single-crystal
X-ray crystallography: a 19·425(1),
b 17·734(1), c
15·979(1) Å, β 117·52(1)˚, monoclinic, space
group C 2/c (No.
15)
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献